NanoViricides
NNVC
#10568
Rank
C$44.23 M
Marketcap
C$1.73
Share price
1.68%
Change (1 day)
-10.30%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: C$44.23 Million

As of November 2026 NanoViricides has a market cap of C$44.23 Million. This makes NanoViricides the world's 10568th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026C$44.23 M25.86%
2025C$35.14 M13.82%
2024C$30.88 M94.33%
2023C$15.89 M-9.13%
2022C$17.48 M-68%
2021C$54.63 M40%
2020C$39.02 M207.58%
2019C$12.68 M-32.99%
2018C$18.93 M-72.98%
2017C$70.08 M-16.26%
2016C$83.69 M-11.58%
2015C$94.64 M-46.99%
2014C$0.17 B-30.17%
2013C$0.25 B243.65%
2012C$74.4 M-19.71%
2011C$92.66 M-54.56%
2010C$0.20 B72.87%
2009C$0.11 B-2.38%
2008C$0.12 B160.69%
2007C$46.35 M

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of NanoViricides was reported to be:

C$43.5 Million
by Nasdaq info icon info icon
C$43.5 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$296.67 B 670,539.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$473.84 B 1,071,016.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$171.09 B 386,650.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$137.65 B 311,056.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C$1.89 B 4,185.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$2.71 B 6,028.44%๐Ÿ‡บ๐Ÿ‡ธ USA